#02 - Rhonda Patrick, Ph.D.: the performance and longevity paradox of IGF-1, ketogenic diets and genetics, the health benefits of sauna, NAD+, and more
The Peter Attia Drive
00:00
Is There a Risk of Inflammation in Cardiovascular Disease?
There was a clinical trial published either earlier this year or last year that looked at an il one antagonist. The question was, could that impact cardio vascular mortality? And we've long talked about how cardio vascular disease is sort of this trifecta of lypa proteins, inflammation, and end eleal disfunction. So the patients getting the il one antagonist, despite having no difference in lipids or any other bi marker, had an improved outcome with respect to carty o vascular health. About a month ago, another trial that was using low dose of metha trexate, which is an immune suppressent, was halted early.
Transcript
Play full episode
